Literature DB >> 12234294

Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy.

Xiaojie Gao1, Hiromu Mae, Nobuhiko Ayabe, Toru Takai, Keisuke Oshima, Masuji Hattori, Takahiro Ueki, Jiro Fujimoto, Takakuni Tanizawa.   

Abstract

BACKGROUND: Unilateral ureteral obstruction (UUO) is characterized by progressive tubular atrophy and interstitial fibrosis. Rupture of the balance between cell proliferation and apoptosis plays a critical role in renal atrophy. Hepatocyte growth factor (HGF) is a cytokine function on cell survival and tissue regeneration. We studied the effects and possible mechanisms of HGF gene therapy on tubular cell survival and anti-fibrosis in chronic obstructed nephropathy.
METHODS: An in vivo transfection procedure of repeatedly transducing skeletal muscles with the HGF gene using liposomes containing the hemagglutinating virus of Japan (HVJ liposome) was tested on UUO rats. Expression of HGF and c-Met were examined by in situ hybridization, ELISA, or immunohistochemical staining. Interstitial fibrosis and macrophage infiltration were evaluated by Masson's Trichrome staining, alpha-smooth muscle actin and ED-1 immunostaining. Cell survival indices including proliferating cell nuclear antigen (PCNA), Bcl-2, Bcl-xL and Bax were measured by immunohistochemistry and Western blots. Apoptosis was determined by the TUNEL method.
RESULTS: After HVJ-HGF gene transfer, endogenous HGF and c-Met were up-regulated in UUO kidneys. Renal fibrosis, macrophage infiltration and tubular atrophy were suppressed both at day 14 and 28 after UUO (P < 0.05 or 0.01). Tubular cell proliferation was activated while apoptosis was inhibited, especially at the late stage of UUO. Bcl-2 was enhanced in the HGF-transfected UUO rats, while no changes of Bcl-xL and Bax were found.
CONCLUSIONS: In vivo HGF gene transfection retards the progression of chronic obstructed nephropathy and protects tubular cell survival in the long-term UUO model. Bcl-2 rather than Bcl-xL or Bax may contribute to the anti-apoptotic function of HGF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234294     DOI: 10.1111/j.1523-1755.2002.kid579.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

Review 1.  Role of kidney biomarkers of chronic kidney disease: An update.

Authors:  Zeba Khan; Manoj Pandey
Journal:  Saudi J Biol Sci       Date:  2014-07-15       Impact factor: 4.219

Review 2.  Oxidative stress in obstructive nephropathy.

Authors:  Amélie Dendooven; David A Ishola; Tri Q Nguyen; Dionne M Van der Giezen; Robbert Jan Kok; Roel Goldschmeding; Jaap A Joles
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

3.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

4.  Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy.

Authors:  María T Grande; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  J Inflamm (Lond)       Date:  2010-04-22       Impact factor: 4.981

5.  Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.

Authors:  Thomas H Sisson; Mai-Huong Nguyen; Bi Yu; Margaret L Novak; Richard H Simon; Timothy J Koh
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

6.  Hepatocyte growth factor exerts its anti-inflammatory action by disrupting nuclear factor-kappaB signaling.

Authors:  Myrto Giannopoulou; Chunsun Dai; Xiaoyue Tan; Xiaoyan Wen; George K Michalopoulos; Youhua Liu
Journal:  Am J Pathol       Date:  2008-05-23       Impact factor: 4.307

Review 7.  Liposome-mediated gene therapy in the kidney.

Authors:  Keiichi Ito; Jie Chen; Tomohiko Asano; E Darracott Vaughan; Dix P Poppas; Masamichi Hayakawa; Diane Felsen
Journal:  Hum Cell       Date:  2004-03       Impact factor: 4.174

8.  Late intervention with the small molecule BB3 mitigates postischemic kidney injury.

Authors:  Prakash Narayan; Bin Duan; Kai Jiang; Jingsong Li; Latha Paka; Michael A Yamin; Scott L Friedman; Matthew R Weir; Itzhak D Goldberg
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-01

9.  Melatonin protects kidney against apoptosis induced by acute unilateral ureteral obstruction in rats.

Authors:  Mehmet Erol Yildirim; Hüseyin Badem; Muzaffer Cakmak; Hakki Yilmaz; Bahadir Kosem; Omer Faruk Karatas; Reyhan Bayrak; Ersin Cimentepe
Journal:  Cent European J Urol       Date:  2016-06-20

10.  Human Wharton's jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells.

Authors:  Tao Du; Xiangyu Zou; Jun Cheng; Shuai Wu; Liang Zhong; Guanqun Ju; Jiang Zhu; Guohua Liu; Yingjian Zhu; Shujie Xia
Journal:  Stem Cell Res Ther       Date:  2013-06-04       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.